Press Release: Ryan Specialty Reports Third Quarter 2025 Results

Dow Jones
2025/10/31

- Total Revenue grew 24.8% year-over-year to $754.6 million -

- Organic Revenue Growth Rate* of 15.0% year-over-year -

- Net Income of $62.6 million, or $0.20 per diluted share -

- Adjusted EBITDAC* grew 23.8% year-over-year to $235.5 million -

- Adjusted Net Income increased 15.9% year-over-year to $131.7 million -

- Adjusted Diluted Earnings Per Share grew 14.6% or $0.47 per diluted share -

CHICAGO--(BUSINESS WIRE)--October 30, 2025-- 

Ryan Specialty Holdings, Inc. (NYSE: RYAN) ("Ryan Specialty" or the "Company"), a leading international specialty insurance firm, today announced results for the third quarter ended September 30, 2025.

Third Quarter 2025 Highlights

   --  Revenue grew 24.8% year-over-year to $754.6 million, compared to $604.7 
      million in the prior-year period 
 
   --  Organic Revenue Growth Rate* was 15.0% for the quarter, compared to 
      11.8% in the prior-year period 
 
   --  Net Income increased 118.6% year-over-year to $62.6 million, compared 
      to $28.6 million in the prior-year period. Diluted Earnings Per Share was 
      $0.20 
 
   --  Adjusted EBITDAC* increased 23.8% to $235.5 million, compared to $190.3 
      million in the prior-year period 
 
   --  Adjusted EBITDAC Margin* of 31.2%, compared to 31.5% in the prior-year 
      period 
 
   --  Adjusted Net Income* increased 15.9% to $131.7 million, compared to 
      $113.6 million in the prior-year period 
 
   --  Adjusted Diluted Earnings Per Share* increased 14.6% to $0.47, compared 
      to $0.41 in the prior-year period 
 
   --  Capital return to stockholders and LLC unit holders was $22.1 million 
      of regular dividends and distributions 

"It was a strong quarter for Ryan Specialty, demonstrating the strength and resilience of our firm throughout a challenging insurance and macro environment," said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. "We grew total revenue 25%, supported by strong organic growth of 15%, and another quarter of excellent contributions from our recent M&A transactions. We grew Adjusted EBITDAC 23.8% and Adjusted Diluted EPS by 14.6%. I am especially proud of what we've achieved while making substantial strategic investments during the quarter to capitalize on excellent opportunities to add broking and underwriting talent to our world-class team, as well as making continued investments in technology. We are well positioned to strengthen our position as an international leader in the specialty lines industry for years to come."

"Our team's relentless execution this quarter underscores the power of our platform, the depth of our expertise, and our unwavering commitment to serving our clients and trading partners," added Timothy W. Turner, Chief Executive Officer of Ryan Specialty. "We are navigating this challenging and transitioning market with confidence, driven by our diverse product offerings, durable business model, and a culture that continues to attract talented professionals. The runway ahead of us is significant, and we remain focused on delivering industry-leading organic growth and long-term value for our shareholders."

Summary of Third Quarter 2025 Results

 
                       Three Months Ended                                  Nine Months Ended 
                           September 30,              Change                  September 30,                 Change 
                    --------------------------  -------------------  ------------------------------  -------------------- 
(in thousands, 
except percentages 
and per share 
data)                 2025          2024           $          %         2025            2024             $          % 
                     -------       -------      --------  ---------   ---------       ---------      ---------  --------- 
GAAP financial 
measures 
   Total revenue    $754,577      $604,694      $149,883   24.8%     $2,299,913      $1,852,181      $447,732    24.2% 
   Net commissions 
    and fees         739,552       588,129       151,423   25.7       2,256,537       1,806,264       450,273    24.9 
   Compensation 
    and benefits     440,434       393,249        47,185   12.0       1,355,995       1,180,825       175,170    14.8 
   General and 
    administrative   117,589        88,684        28,905   32.6         330,698         247,518        83,180    33.6 
   Total operating 
    expenses         643,786       523,217       120,569   23.0       1,897,835       1,533,687       364,148    23.7 
   Operating 
    income           110,791        81,477        29,314   36.0         402,078         318,494        83,584    26.2 
   Net income         62,603        28,643        33,960  118.6         182,919         187,358        (4,439)   (2.4) 
   Net income 
    attributable 
    to Ryan 
    Specialty 
    Holdings, 
    Inc.              31,085        17,589        13,496   76.7          55,419          80,911       (25,492)  (31.5) 
   Compensation 
    and benefits 
    expense ratio 
    (1)                 58.4%         65.0%                                59.0%           63.8% 
   General and 
    administrative 
    expense ratio 
    (2)                 15.6%         14.7%                                14.4%           13.4% 
   Net income 
    margin (3)           8.3%          4.7%                                 8.0%           10.1% 
   Earnings per 
    share (4)       $   0.24      $   0.15                           $     0.44      $     0.67 
   Diluted 
    earnings per 
    share (4)       $   0.20      $   0.09                           $     0.41      $     0.59 
Non-GAAP financial 
measures* 
   Organic revenue 
    growth rate         15.0%         11.8%                                11.4%           13.3% 
   Adjusted 
    compensation 
    and benefits 
    expense         $417,217      $343,442      $ 73,775   21.5%     $1,268,059      $1,057,424      $210,635    19.9% 
   Adjusted 
    compensation 
    and benefits 
    expense ratio       55.3%         56.8%                                55.1%           57.1% 
   Adjusted 
    general and 
    administrative 
    expense         $101,827      $ 70,991      $ 30,836   43.4%     $  287,414      $  199,583      $ 87,831    44.0% 
   Adjusted 
    general and 
    administrative 
    expense ratio       13.5%         11.7%                                12.5%           10.8% 
   Adjusted 
    EBITDAC         $235,533      $190,261      $ 45,272   23.8%     $  744,440      $  595,174      $149,266    25.1% 
   Adjusted 
    EBITDAC 
    margin              31.2%         31.5%                                32.4%           32.1% 
   Adjusted net 
    income          $131,704      $113,633      $ 18,071   15.9%     $  424,225      $  369,604      $ 54,621    14.8% 
   Adjusted net 
    income margin       17.5%         18.8%                                18.4%           20.0% 
   Adjusted 
    diluted 
    earnings per 
    share           $   0.47      $   0.41      $   0.06   14.6%     $     1.52      $     1.34      $   0.18    13.4% 
 
 
*        For a definition and a reconciliation of Organic revenue growth rate, 
         Adjusted compensation and benefits expense, Adjusted compensation and 
         benefits ratio, Adjusted general and administrative expense, Adjusted 
         general and administrative expense ratio, Adjusted EBITDAC, Adjusted 
         EBITDAC margin, Adjusted net income, Adjusted net income margin, and 
         Adjusted diluted earnings per share to the most directly comparable 
         GAAP measure, see "Non-GAAP Financial Measures and Key Performance 
         Indicators" below. 
 
(1)      Compensation and benefits expense ratio is defined as Compensation 
         and benefits divided by Total revenue. 
(2)      General and administrative expense ratio is defined as General and 
         administrative expense divided by Total revenue. 
(3)      Net income margin is defined as Net income divided by Total revenue. 
(4)      See "Note 9, Earnings Per Share" of the unaudited quarterly 
         consolidated financial statements. 
 

Third Quarter 2025 Review*

Total revenue for the third quarter of 2025 was $754.6 million, an increase of 24.8% compared to $604.7 million in the prior-year period. This increase was primarily due to continued organic revenue growth of 15.0%, driven by new client wins and expanded relationships with existing clients, coupled with continued expansion of the specialty and E&S markets, revenue from acquisitions completed within the trailing twelve months ended September 30, 2025, changes in contingent commissions, and the impact of foreign exchange rates. We experienced growth across the majority of our casualty lines and modest growth in property lines across all three specialties.

Total operating expenses for the third quarter of 2025 were $643.8 million, a 23.0% increase compared to $523.2 million in the prior-year period. This increase was primarily due to higher Compensation and benefits expenses compared to the prior-year period resulting from higher compensation due to growth in headcount and revenue, partially offset by a decrease in Restructuring and related expenses due to the completion of the ACCELERATE 2025 program, lower Equity-based compensation, and lower Acquisition related long-term incentive compensation. General and administrative expense also increased compared to the prior-year period due to an increase in professional services and IT charges associated with ongoing technology and data initiatives as well as costs directly linked to revenue growth, recruiter fees, and higher expenses to accommodate both organic and inorganic revenue growth, partially offset by lower Restructuring and related expenses due to the completion of the ACCELERATE 2025 program.

(MORE TO FOLLOW) Dow Jones Newswires

October 30, 2025 16:05 ET (20:05 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10